Nuwellis, Inc. (NUWE)

USD 1.0

(2.3%)

Market Cap (In USD)

4.37 Million

Revenue (In USD)

8.86 Million

Net Income (In USD)

-20.2 Million

Avg. Volume

462.25 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.97-30.1
PE
-
EPS
-
Beta Value
0.359
ISIN
US67113Y4052
CUSIP
12542Q706
CIK
1506492
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Nestor Jaramillo Jr.
Employee Count
-
Website
https://www.nuwellis.com
Ipo Date
2012-02-16
Details
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.